Brief: Plus Therapeutics Regains Compliance With Applicable Nasdaq Listing Criteria
26/08/2025 12:31
Aug 26 (Reuters) - Plus Therapeutics Inc PSTV.O: PLUS THERAPEUTICS REGAINS COMPLIANCE WITH APPLICABLE NASDAQ LISTING CRITERIA Source text: ID:nGNX4gMfhX Further company coverage: PSTV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer